Lessons from London
This blog explores how clinical research leaders are navigating post-Covid uncertainty, shifting buyer expectations, and the growing need for authenticity, trust, and AI-driven value.
Dose Optimization in Oncology: Advancing Clinical Trial Quality
The FDA’s latest guidance on dose optimization marks a pivotal shift in oncology drug development.
New FDA Guidance Reshapes Decentralized Trial Oversight
The FDA’s new guidance on marks a pivotal shift in clinical research, promoting accessibility while emphasizing the need for enhanced risk oversight.